Selected Papers

Methodological

Uno H, Tian L, Wei L J. The optimal confidence region for a random parameter. Biometrika 2005;92:957-64.

Uno H, Cai T, Tian L, Wei LJ. Evaluating prediction rules for t-year survivors with censored regression models. Journal of the American Statistical Association 2007;102:527-537.

Uno H, Cai T, Pencina MJ, D’Agostino R, Wei LJ. On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data, Statistics in Medicine 2011; 30:1105-1117.
[R-package: survC1]

Uno H, Cai T, Tian L, Wei LJ. Graphical Procedures for Evaluating Overall and Subject-specific Incremental Values from New Predictors with Censored Event Time Data, Biometrics 2011; 67(4):1389-96.

Uno H, Tian L, Cai T, Kohane IS, Wei LJ. A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data, Statistics in Medicine 2012, accepted.
[R-package: survIDINRI]



Clinical

Solomon SD, Uno H, Lewis E, Eckardt KW, Burdmann EA, Cooper ME, de Zeeuw D, Ivanovich P, Levey AS, Parfrey P, Remuzzi G, Singh AK, Toto R, Huang F, Rossert J, McMurray JV, Pfeffer MA for the TREAT Investigators. Erythropoietic response and outcomes in kidney disease and type 2 diabetes. The New England Journal of Medicine, 2010, 363 (12): 1146-55.

Cripe LD, Uno H, Paiettta EP, Litzow MR, Ketterling RP, Bennett JM, Rowe JM, Lazarus HM, Luger S, Tallman MS. Zosquidar, a novel modulator of P-gp, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled, trial of the Eastern Cooperative Oncology Group (ECOG 3999), Blood, 2010, 116: 4077-85.

Kumar S, Uno H, Jacobus S, Wier SV, Ahmann G, Henderson K, Callander N, Haug J, Siegel D, Greipp P, Fonseca R, Rajkumar V. Impact of gene expression profiling-based risk stratification in patients with myeloma receiving initial therapy with lenalidomide and dexamethasone, Blood 2011, 118(16):4359-62.